sar
epidem
mani
patient
receiv
corticosteroid
therapi
counter
often
sever
symptom
acut
respiratori
distress
epidem
sever
report
chines
intern
literatur
occurr
avascular
osteonecrosi
avn
hong
du
griffith
et
al
li
et
al
avn
due
impair
circul
blood
area
bone
caus
subsequ
necrosi
et
al
condit
may
idiopath
associ
variou
condit
trauma
corticosteroid
usag
alcohol
infect
blood
disord
autoimmun
diseas
high
dose
corticosteroid
given
short
period
time
patient
predispos
avn
gener
confer
high
risk
avn
wing
et
al
high
dose
corticosteroid
given
longer
period
time
patient
predispos
avn
patient
system
lupu
erythematosu
strongli
correl
avn
felson
anderson
question
aros
risk
factor
avn
observ
sar
patient
sole
associ
amount
durat
corticosteroid
treatment
predispos
factor
paper
describ
cohort
patient
beij
time
year
investig
relationship
osteonecrosi
incid
igg
antibodi
titr
enrol
treatment
dose
corticosteroid
patient
diagnos
cpaf
hospit
beij
march
april
clinic
present
fulfil
nation
depart
health
definit
probabl
sar
cdc
diagnosi
sar
subsequ
confirm
serolog
immunosorb
assay
elisa
neutral
assay
specif
antibodi
sar
coronaviru
liu
et
al
patient
employe
hospit
infect
two
known
sourc
inpati
hospit
time
colleagu
medic
personnel
size
outbreak
mani
infect
employe
refer
three
hospit
citi
treatment
return
cpaf
hospit
around
end
june
recoveri
time
first
case
avn
found
decid
examin
whole
group
patient
presenc
avn
individu
total
patient
follow
year
june
visit
everi
month
sar
patient
given
treatment
accord
protocol
variou
hospit
time
anonym
indic
administ
corticosteroid
includ
one
follow
criteria
sever
toxic
symptom
persist
high
fever
use
analges
day
problem
includ
heat
loss
ill
progress
within
h
lesion
expand
exceed
total
lung
area
posit
chest
radiograph
diagnost
criteria
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
recommend
dose
methylprednisolon
adult
mgday
intraven
modif
made
accord
need
individu
patient
sar
patient
underw
magnet
reson
imag
mri
cpaf
hospit
beij
part
assess
use
instrument
ge
usa
imag
taken
hip
knee
shoulder
ankl
wrist
two
musculoskelet
radiologist
one
year
experi
one
year
experi
interpret
mri
examin
find
reach
consensu
osteonecrosi
defin
subchondr
intramedullari
area
demarc
distinct
margin
rim
encompass
medullari
fat
centr
arco
classif
osteonecrosi
use
describ
condit
hip
gardeni
digit
classif
refer
arco
stage
natur
radiograph
find
letter
refer
subclass
express
locat
lesion
extens
lesion
weight
bear
dome
acetabulum
femor
head
medial
b
central
c
later
quantif
abnorm
given
arco
stage
indic
moder
stage
sever
avn
osteonecrosi
identifi
shoulder
knee
ankl
andor
wrist
classifi
posit
osteonecrosi
present
neg
osteonecrosi
present
patient
avn
refer
specialist
treatment
receiv
appropri
therapi
includ
physiotherapi
andor
hip
replac
accord
standard
guidelin
treatment
corticosteroid
discontinu
diagnosi
avn
collect
patient
age
sex
profess
health
worker
worker
patient
follow
inform
corticosteroid
treatment
avail
total
dose
corticosteroid
cumul
given
mg
maxim
dose
per
day
durat
treatment
inform
condit
joint
record
describ
final
igg
antibodi
titr
ill
record
condit
diseas
lead
avn
rule
histori
bone
diseas
paget
diseas
fractur
osteoporosi
diseas
affect
bone
metabol
renal
failur
thyrotoxicosi
hyperparathyroid
patient
known
alcohol
abus
intraven
drug
use
joint
pain
sar
univari
logist
regress
analysi
perform
identifi
associ
avn
risk
factor
continu
variabl
test
categor
continu
addit
test
ad
squar
term
use
valu
result
significantli
better
fit
data
variabl
univari
analysi
signific
p
enter
multivari
logist
regress
model
best
model
obtain
use
standard
backward
stepwis
likelihood
ratio
method
softwar
packag
use
analysi
spss
version
total
former
sar
patient
follow
durat
month
durat
start
corticosteroid
treatment
first
assess
month
time
first
assess
month
patient
diagnos
avn
tabl
three
patient
bilater
hip
involv
nine
bone
abnorm
joint
well
sever
avn
arco
stage
present
case
eight
patient
requir
hip
replac
surgeri
month
anoth
two
patient
develop
bilater
hip
avn
arco
stage
bring
percentag
avn
month
month
new
instanc
avn
observ
month
howev
total
new
case
found
bone
abnorm
joint
hip
new
case
bilater
avn
hip
arco
stage
addit
four
case
previou
hip
involv
develop
bone
abnorm
joint
brought
total
number
patient
avn
joint
month
figur
b
give
exampl
mri
imag
hip
knee
joint
patient
diagnos
avn
tabl
show
distribut
moder
n
sever
n
avn
hip
avn
hip
n
accord
age
sex
corticosteroid
treatment
initi
antibodi
titr
patient
lowest
age
categori
year
follow
age
year
patient
year
addit
slight
major
patient
femal
age
sex
distribut
reflect
fact
patient
healthcar
worker
half
patient
receiv
maxim
dose
corticosteroid
mg
patient
receiv
maxim
dose
mg
less
four
patient
receiv
extrem
high
maxim
dose
mg
averag
durat
treatment
day
vari
wide
day
averag
total
dose
mg
wide
rang
mg
eight
case
possibl
obtain
initi
antibodi
titr
remain
case
titr
posit
rang
patient
found
avn
joint
hip
end
observ
period
gener
lower
treatment
indic
maxim
dose
durat
treatment
total
dose
other
surpris
individu
rel
low
dose
remain
develop
avn
joint
later
stage
tabl
show
risk
factor
develop
avn
hip
within
year
treatment
sar
corticosteroid
univari
logist
regress
analysi
perform
case
develop
moder
sever
avn
hip
among
cohort
surviv
sar
patient
statist
signific
p
associ
avn
hip
age
sex
patient
associ
log
antibodi
titr
nearli
statist
signific
p
factor
howev
relat
treatment
corticosteroid
show
strong
associ
p
multivari
regress
analysi
includ
three
treatment
factor
log
antibodi
titr
hospit
result
model
total
dose
cumul
dose
remain
statist
signific
fact
model
includ
maximum
dose
durat
treatment
give
wors
fit
data
shown
repeat
analysi
sever
avn
hip
n
give
similar
result
larger
confid
interv
multivari
analysi
howev
maxim
dose
instead
total
dose
remain
statist
signific
factor
ci
p
test
risk
sever
avn
hip
n
develop
avn
hip
n
result
signific
factor
shown
suggest
degre
sever
avn
hip
random
yet
unknown
factor
paper
describ
cohort
sar
patient
treat
high
dose
corticosteroid
acut
phase
diseas
group
develop
avascular
necrosi
hip
within
month
start
treatment
two
case
hip
necrosi
seen
year
anoth
case
avn
diagnos
year
one
hip
necrosi
necrosi
joint
total
cohort
develop
avascular
necrosi
year
observ
sole
factor
explain
avascular
necrosi
hip
total
dose
corticosteroid
receiv
occurr
avn
bone
sar
patient
report
soon
outbreak
sar
china
hong
du
shen
et
al
analys
complic
follow
subsequ
griffith
et
al
chan
et
al
report
howev
cohort
former
sar
patient
treat
corticosteroid
present
paper
fill
gap
limit
studi
absenc
control
patient
inher
fact
data
outbreak
situat
allow
randomis
patient
receiv
treatment
addit
possibl
determin
extent
diseas
sar
possibl
contribut
avn
patient
previou
report
underlin
short
durat
onset
sar
diagnosi
avn
hong
du
report
mean
time
day
li
et
al
indic
case
avn
detect
within
month
start
corticosteroid
treatment
chan
et
al
describ
median
time
admiss
mri
examin
cohort
sar
patient
month
rang
month
studi
abl
calcul
accur
time
onset
sar
diagnosi
avn
miss
data
patient
avn
diagnos
month
start
corticosteroid
treatment
known
gener
interv
corticosteroid
administr
onset
symptom
rare
less
month
may
year
rist
rist
median
durat
month
report
koo
et
al
report
preval
avn
sar
patient
treat
corticosteroid
vari
remark
hong
kong
preval
griffith
et
al
chan
et
al
report
one
hospit
beij
report
preval
li
et
al
studi
also
hospit
beij
report
preval
shortli
end
sar
epidem
studi
diagnosi
avn
base
mri
preval
report
literatur
avn
corticosteroid
treatment
approxim
mankin
mulliken
et
al
preval
report
studi
goe
far
beyond
figur
certainli
take
account
new
case
avn
found
whole
period
year
intrigu
question
certainli
absenc
comprehens
studi
former
sar
patient
treat
corticosteroid
mani
patient
still
suffer
avn
result
disabl
given
preval
figur
beij
number
substanti
whole
china
unfortun
know
case
whether
situat
beij
special
term
patient
select
dose
given
studi
show
interest
distribut
occurr
avn
time
case
found
within
month
start
corticosteroid
treatment
case
often
seriou
hip
involv
second
group
appear
month
less
seriou
primarili
joint
involv
hip
second
group
distinguish
first
group
lower
treatment
indic
lower
maxim
dose
shorter
durat
treatment
lower
total
dose
group
case
avn
hip
one
found
first
month
observ
avn
could
explain
complet
total
cumul
dose
corticosteroid
receiv
griffith
et
al
found
hong
kong
griffith
et
al
studi
hong
kong
corticosteroid
extend
durat
treatment
shown
signific
risk
factor
avn
chan
et
al
previou
studi
beij
hospit
howev
maximum
daili
dose
shown
signific
risk
factor
studi
found
includ
case
seriou
avn
hip
multivari
regress
analysi
could
indic
occurr
per
se
avn
primarili
depend
total
dose
sever
avn
relat
maximum
daili
dose
studi
underlin
risk
corticosteroid
treatment
occurr
avn
bone
case
sar
howev
uniqu
diseas
treatment
experi
felt
corticosteroid
necessari
counter
acut
respiratori
distress
syndrom
critic
ill
patient
save
live
experi
gain
cours
epidem
treatment
regimen
adjust
accordingli
use
corticosteroid
debat
conflict
opinion
steroid
key
compon
treatment
sar
gomersal
remain
uncertain
aggress
use
corticosteroid
sar
epidem
tip
balanc
save
live
appli
corticosteroid
high
dose
immedi
benefit
term
save
live
weigh
advers
effect
includ
avn
perhap
low
sar
case
fatal
mainland
china
rel
affect
countri
area
extent
result
treatment
feng
et
al
suggest
randomis
control
trial
perform
solv
issu
effect
corticosteroid
circumst
acut
respiratori
diseas
research
protocol
initi
promptli
sar
compar
diseas
return
gomersal
et
al
author
declar
conflict
interest
